Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluated the effects of hypertonic saline solution (3% NaCl plus bicarbonate) on nasal inflammation in children with allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic saline solution 3% NaCl + NaHCO3 (Hypertonic saline with bicarbonate)

Snippet

Sponsor: Stefania La Grutta, MD | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED